ScholarIQanswers from OpenAlex & ORCID
Jie He
ResearcherPublications, citations & collaboration network
Jie He is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jie He have?
ScholarIQindexed works
Jie He has 953 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jie He have?
ScholarIQcitation count
Jie He has 57,526 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jie He?
ScholarIQh-index
Jie He has an h-index of 92 in OpenAlex.
What is the i10-index of Jie He?
ScholarIQi10-index
Jie He has an i10-index of 493 in OpenAlex.
What is the ORCID of Jie He?
ScholarIQorcid
The ORCID for Jie He is on the source record.
What is the OpenAlex record for Jie He?
ScholarIQopenalex
The OpenAlex for Jie He is on the source record.
What are the most-cited papers on Jie He?
ScholarIQmost cited works
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton, Alex Fichtenholtz, Geoff Otto, Kai Wang, Sean R. Downing, Jie He, Michael Schnall-Levin, Jared White, Eric M. Sanford, Peter An, James Sun, Frank Juhn, Kristina Brennan, Kiel Iwanik, Ashley Maillet, Jamie Buell, Emily White, Mandy Zhao, Sohail Balasubramanian, Selmira Terzic, Tina Richards, Vera Banning, Lázaro Ibrahim Romero García, Kristen Mahoney, Zac Zwirko, Amy Donahue, Himisha Beltran, Juan Miguel Mosquera, Mark A. Rubin, Snjezana Doğan, Cyrus V. Hedvat, Michael F. Berger, Lajos Pusztai, Matthias Lechner, Chris Boshoff, Mirna Jarosz, Christine Vietz, Alex Parker, Vincent A. Miller, Jeffrey S. Ross, John A. Curran, Maureen Cronin, Philip J. Stephens, Doron Lipson, Roman Yelensky
Perioperative Nivolumab in Resectable Lung Cancer
Tina Cascone, Mark M. Awad, Jonathan Spicer, Jie He, Shun Lü, Boris Sepesi, Fumihiro Tanaka, Janis M. Taube, Robin Cornelissen, Libor Havel, Nina Karaseva, Jarosław Kużdżał, Luboš Petruželka, Lin Wu, Jean-Louis Pujol, Hiroyuki Ito, Tudor–Eliade Ciuleanu, Ludmila de Oliveira Muniz Koch, Annelies Janssens, Aurelia Alexandru, Sabine Bohnet, Fedor V. Moiseyenko, Yang Gao, Yasutaka Watanabe, Cinthya Coronado Erdmann, Padma Sathyanarayana, S. Meadows–Shropshire, Steven I. Blum, Mariano Provencio
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
Shugeng Gao, Ning Li, Shun‐Yu Gao, Qi Xue, Jianming Ying, Shuhang Wang, Xiuli Tao, Jun Zhao, Yousheng Mao, Bing Wang, Kang Shao, Wendong Lei, Dali Wang, Fang Lv, Liang Zhao, Fan Zhang, Ziran Zhao, Kai Su, Fengwei Tan, Yibo Gao, Nan Sun, Dawei Wu, Yue Yu, Yun Ling, Zhijie Wang, Chunjian Duan, Wei Tang, Lei Zhang, Shun He, Ning Wu, Jie Wang, Jie He
Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma
Yong Guo, Zhaoli Chen, Liang Zhang, Fang Zhou, Susheng Shi, Xiaoli Feng, Baozhong Li, Xin Meng, Xi Ma, Mingyong Luo, Kang Shao, Ning Li, Bin Qiu, Keith Mitchelson, Jing Cheng, Jie He
The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity
Chengming Liu, Sufei Zheng, Runsen Jin, Xin‐Feng Wang, Rui Wang, Ruochuan Zang, Haiyan Xu, Zhiliang Lu, Jianbing Huang, Yuanyuan Lei, Shuangshuang Mao, Yalong Wang, Yalong Wang, Xiaoli Feng, Nan Sun, Yan Wang, Yan Wang, Jie He